The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including treatment with the ERK inhibitor ulixertinib.
 
Eli L. Diamond
Consulting or Advisory Role - Day One Biopharmaceuticals; SpringWorks Therapeutics
(OPTIONAL) Uncompensated Relationships - Pfizer
 
Mariko Yabe
Consulting or Advisory Role - Janssen
 
Kseniya Petrova-Drus
No Relationships to Disclose
 
Marc Rosenblum
No Relationships to Disclose
 
Veronica Rotemberg
Stock and Other Ownership Interests - Johnson and Johnson (I)
Consulting or Advisory Role - Inhabit Brands
 
Mario E. Lacouture
Stock and Other Ownership Interests - Oncoderm (I)
Honoraria - Apricity Health; AstraZeneca; Deciphera; Incyte; Innovaderm; Janssen; L'Oreal; La Roche-Posay; Lutris; MJH Associates; Nanology; Novartis; Novocure; OnQuality Pharmaceuticals; RBC consultants; Relay Therapeutics; Roche/Genentech; Seattle Genetics/Astellas; Tyra Biosciences
Consulting or Advisory Role - Apricity Health; AstraZeneca; Deciphera; Genentech; Incyte; Innovaderm; Janssen Research & Development; La Roche-Posay; Lutris; Novartis; Novocure; OnQuality Pharmaceuticals; Relay Therapeutics; Roche; Roche; Seagen; Tyra Biosciences
Research Funding - AstraZeneca/MedImmune (Inst); Columbia University (Inst); Lutris; National Jewish Health (Inst); Novartis (Inst); Novocure; Paxman; US Biotest
Other Relationship - Oncoderm (I)
(OPTIONAL) Uncompensated Relationships - Oncoderm
 
Raajit Rampal
Consulting or Advisory Role - Abbvie; Blueprint Medicines; Celgene; Constellation Pharmaceuticals; CTI; Disc Medicine; Galecto; Incyte; Jazz Pharmaceuticals; Novartis; PharmaEssentia; Promedior; Sierra Oncology; Stemline Therapeutics; Sunimoto Dainippon
Research Funding - Constellation Pharmaceuticals; Incyte; Stemline Therapeutics; Zentalis
 
Jasmine Francis
No Relationships to Disclose
 
Deb Knoerzer
Employment - BioMed Valley Discoveries
Stock and Other Ownership Interests - Pfizer
Research Funding - BioMed Valley Discoveries (Inst)
 
Brent Kreider
Employment - BioMed Valley Discoveries
Leadership - BioMed Valley Discoveries
 
Omar Ibrahim Abdel-Wahab
Consulting or Advisory Role - AlChemy; Envisagenics; Foundation Medicine; H3 Biomedicine; Janssen; Merck; Pfizer; Prelude Therapeutics
Research Funding - H3 Biomedicine; Loxo
 
Benjamin Heath Durham
No Relationships to Disclose